Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Emilia Ragot is a leading figure in pancreatic surgery, whose work has fundamentally reshaped our understanding of minimally invasive left pancreatectomy (MILP). Her primary research focuses on optimizing surgical outcomes through rigorous risk stratification and predictive modeling. Dr. Ragot’s most impactful contribution is the development of the Conversion Risk Score (CRS), a validated clinical tool that identifies patients at high risk for conversion from MILP to open surgery. This work, detailed in her highly cited 2025 paper, addresses a critical challenge: conversion occurs in 15-30% of MILP cases and is strongly associated with severe postoperative complications. By pinpointing key risk factors, her CRS enables surgeons to personalize operative planning, reducing unnecessary morbidity. With 4 citations already, her research is rapidly shaping clinical guidelines. Dr. Ragot’s achievements include pioneering the integration of predictive analytics into pancreatic surgical decision-making, earning her recognition as a rising authority in hepato-pancreato-biliary surgery. Her work not only advances patient safety but also provides a replicable framework for risk assessment in complex minimally invasive procedures.